DGAP-News: Press Ventures Acquires Exclusive Global License to Patented Biosafety Technology in $50 Billion Virus and Bacteria Security Market
(firmenpresse) - Press Ventures, Inc.
26.08.2013 14:48
---------------------------------------------------------------------------
WARSAW, Poland, 2013-08-26 14:47 CEST (GLOBE NEWSWIRE) --
Press Ventures Inc. (OTCQB:PVEN) ('Press Ventures' or the 'Company'), is
pleased to announce that it has secured the global sales and marketing rights
to a patented all-natural essential oil disinfectant and diffusing system that
has been shown to effectively combat and eradicate infection from molds,
fungus, and airborne viruses.
Due to the increased frequency, potential, and public awareness of global
pandemics, virus outbreaks, and food bacteria deaths, the demand for a proven
all-natural biosafety solution has never been greater. The Company believes
that it now has the best natural and safe solution available to combat these
global outbreaks which threaten the world's population. Press Ventures expects
to immediately move forward to exploit new business opportunities worldwide
with the patented all-natural cedar oil disinfectant and diffusing system
technologies.
'We're very optimistic about the timing and the global scale of the opportunity
here and felt that the public market was the best venue to finance and launch
this exciting biosafety technology,' said Edward Denkiewicz, CEO of Press
Ventures. 'We are now in a unique position to build a fantastic business based
on this technology and to help people all over the world combat the spread of
harmful bacteria, molds, fungus, and airborne viruses in their own homes,
businesses, and schools.'
The global market for virus and bacteria security is estimated to be valued at
over $50 billion annually. North America constitutes the largest share of the
infection control market, followed by Europe, Asia, and South America. The
overall rise in number of chronic diseases, pandemic disease outbreaks (such as
H1N1), and an aging population has enhanced the growth and importance of this
market. Cost-containment issues have also led to the growth of the services
sterilization market. The lack of government funds, however, has led to a
decrease in innovation and enhancement of current technologies used for
sterilization and disinfection. The Asian market is expected to display
particularly favorable growth in the coming years primarily due to rise in
health awareness, growth of aging population, increase in number of surgical
procedures, and growth in per capita income.
Additional information regarding the Company's biosafety technology business
and the licensing agreement can be found in a 'Super 8-K' filed with the
Securities and Exchange Commission on their EDGAR system (www.sec.gov).
Notice Regarding Forward-Looking Statements
This news release contains 'forward-looking statements' as that term is defined
in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e)
of the Securities Exchange Act of 1934, as amended. Statements in this press
release that are not purely historical are forward-looking statements and
include any statements regarding beliefs, plans, expectations or intentions
regarding the future. Such forward-looking statements include, among other
things, demand for natural biosafety solutions, exploitation of business
opportunities, strategic business goals, size of the global market for virus
and bacteria security, rise in diseases, growthof the services sterilization
market, growth of the Asian market, our business and product development plans
and projections, and market information. Actual results could differ from those
projected in any forward-looking statements due to numerous factors. Such
factors include, among others, the inherent uncertainties associated with
developing new products or technologies and operating as a development stage
company, our ability to retain important members of our management team and
attract other qualified personnel, our ability to raise the additional funding
we will need to continue to pursue our business and product development plans,
our ability to develop and commercialize products based on our technology
platform, and market conditions. These forward-looking statements are made as
of the date of this news release, and we assume no obligation to update the
forward-looking statements, or to update the reasons why actual results could
differ from those projected in the forward-looking statements. Although we
believe that any beliefs, plans, expectations and intentions contained in this
press release are reasonable, there can be no assurance that any such beliefs,
plans, expectations or intentions will prove to be accurate. Investors should
consult all of the information set forth herein and should also refer to the
risk factors disclosure outlined in the reports and other documents we file
with the SEC, available at www.sec.gov.
CONTACT: Investor Relations Contact:
1-888-709-1550
IR(at)kingstonir.net
News Source: NASDAQ OMX
26.08.2013 Dissemination of a Corporate News, transmitted by DGAP -
a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Press Ventures, Inc.
United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US74112U2024
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 26.08.2013 - 14:48 Uhr
Sprache: Deutsch
News-ID 290867
Anzahl Zeichen: 7520
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 253 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Press Ventures Acquires Exclusive Global License to Patented Biosafety Technology in $50 Billion Virus and Bacteria Security Market"
steht unter der journalistisch-redaktionellen Verantwortung von
Press Ventures, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
